Table 1.
Clinicopathological characteristics according to neutrophil/lymphocyte ratio.
| Variable | n (%) (n=462) | Neutrophil/lymphocyte ratio | p value | |
|---|---|---|---|---|
| ≤1.8 (n=242) | >1.8 (n=220) | |||
| Age | 0.011 | |||
| <50 years | 162 (35.1) | 98 (40.5) | 64 (29.1) | |
| ≥50 years | 300 (64.9) | 144 (59.5) | 156 (70.9) | |
| Stage | 0.195 | |||
| IA2 | 42 (9.1) | 26 (10.7) | 16 (7.3) | |
| IB1 | 420 (90.9) | 216 (89.3) | 204 (92.7) | |
| Histology | 0.424 | |||
| Squamous carcinoma | 270 (58.5) | 134 (55.4) | 136 (61.8) | |
| Adenocarcinoma | 153 (33.1) | 86 (35.5) | 67 (30.5) | |
| Adenosquamous carcinoma | 26 (5.6) | 16 (6.6) | 10 (4.5) | |
| Others | 13 (2.8) | 6 (2.5) | 7 (3.2) | |
| Tumor size | 0.045 | |||
| ≤2 cm | 311 (67.3) | 173 (71.5) | 138 (62.7) | |
| >2 cm | 151 (32.7) | 69 (28.5) | 82 (37.3) | |
| Lymph vascular space invasion | 0.630 | |||
| No | 347 (75.1) | 184 (76.0) | 163 (74.1) | |
| Yes | 115 (24.9) | 58 (24.0) | 57 (25.9) | |
| Deep stromal invasion | 0.353 | |||
| No | 341 (73.8) | 183 (75.6) | 158 (71.8) | |
| Yes | 121 (26.2) | 59 (24.4) | 62 (28.2) | |
| Parametrial involvement | 0.982 | |||
| No | 443 (95.9) | 232 (95.9) | 211 (95.9) | |
| Yes | 19 (4.1) | 10 (4.1) | 9 (4.1) | |
| Lymph node status | 0.280 | |||
| No | 438 (94.8) | 232 (95.8) | 206 (93.6) | |
| Yes | 24 (5.2) | 10 (4.1) | 14 (6.4) | |
| Vaginal margin | 0.837 | |||
| No | 444 (96.1) | 233 (96.3) | 211 (95.9) | |
| Yes | 18 (3.9) | 9 (3.7) | 9 (4.1) | |
| Adjuvant treatment | 0.005 | |||
| No | 368 (79.7) | 205 (84.7) | 163 (74.1) | |
| Yes | 94 (20.3) | 37 (15.3) | 57 (25.9) | |